It's key for clinicians to optimize therapy prior to systemic agents.
Aderonke Adeboye, PharmD, BCPS
Advertisement
Articles by Aderonke Adeboye, PharmD, BCPS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
COVID-19 mRNA Vaccines May Boost Immunotherapy Response in Cancer
2
FDA, HHS Move to Accelerate Biosimilar Approvals
3
KEYNOTE Trial Data Presented at ESMO 2025 Congress Reiterate Pembrolizumab’s Benefits in NSCLC
4
Accelerated Approval of Cancer Drugs: Benefit or Burden?
5
